Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

10.2K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.2K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.8K
3.8K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

2.0K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.0K
Types of RNA01:20

Types of RNA

16.2K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
16.2K
Types of RNA01:23

Types of RNA

73.8K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
73.8K
Inflammation01:38

Inflammation

64.2K
Overview
64.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modified langendorff-free method for isolating cardiomyocytes and non-cardiomyocytes from adult mice.

BMC biotechnology·2026
Same author

Two birds with one stone: Targeting METTL3 ameliorates doxorubicin-induced endothelial premature senescence and atherosclerosis while potentiating its antitumor efficacy.

Free radical biology & medicine·2026
Same author

Single-lumen microcatheter based reversed wire technique (RWT) in the treatment of extremely angled coronary bifurcation lesions.

Cardiovascular intervention and therapeutics·2026
Same author

YTHDC1 Orchestrates Telomerase Assembly via Scaffold-Mediated TERT-TERC Interaction.

Aging cell·2025
Same author

METTL3/RBM15 augments the stability of Kdm6b mRNA and promotes STAT1-mediated macrophage activation and atherosclerosis.

Experimental & molecular medicine·2025
Same author

Engineered probiotic ameliorates hyperlipidemia and atherosclerosis by secreting PCSK9 nanobodies and regulating gut microbiota.

Bioengineering & translational medicine·2025
Same journal

Beyond Sinus Rhythm: Rhythm Control and Mechanism-Based Secondary Prevention in Atrial Fibrillation-Related Stroke.

Journal of atherosclerosis and thrombosis·2026
Same journal

Efficacy and Safety of Evinacumab in Japanese Patients with Homozygous Familial Hypercholesterolemia: Long-term Results from an Open-label, Single-arm, Phase 3 Trial.

Journal of atherosclerosis and thrombosis·2026
Same journal

Knowledge Gaps and Nonadherence Among Japanese Patients with Atherosclerotic Cardiovascular Disease.

Journal of atherosclerosis and thrombosis·2026
Same journal

Association of Multimodal Intracoronary Imaging-Derived Plaque Morphology with the Pathophysiological Disease Patterns Assessed by the Quantitative Flow Ratio-Pullback Pressure Gradient.

Journal of atherosclerosis and thrombosis·2026
Same journal

Prognostic Significance of Atrial Cardiopathy in Patients with Embolic Stroke of an Undetermined Source.

Journal of atherosclerosis and thrombosis·2026
Same journal

Two Sides of the Same Curve: Targets, Reduction, and LDL-C Burden.

Journal of atherosclerosis and thrombosis·2026
See all related articles

Related Experiment Video

Updated: Mar 28, 2026

A Model of Disturbed Flow-Induced Atherosclerosis in Mouse Carotid Artery by Partial Ligation and a Simple Method of RNA Isolation from Carotid Endothelium
11:00

A Model of Disturbed Flow-Induced Atherosclerosis in Mouse Carotid Artery by Partial Ligation and a Simple Method of RNA Isolation from Carotid Endothelium

Published on: June 22, 2010

30.3K

Long Noncoding RNAs in Atherosclerosis.

Liguo Jian1, Dongdong Jian, Qishan Chen

  • 1Department of Cardiology, The Second Affiliated Hospital of Zhengzhou University.

Journal of Atherosclerosis and Thrombosis
|December 25, 2015
PubMed
Summary
This summary is machine-generated.

Long noncoding RNAs (lncRNAs) are key regulators in biological processes. This review highlights lncRNAs involved in atherosclerosis development, offering insights for future research.

More Related Videos

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

13.8K

Related Experiment Videos

Last Updated: Mar 28, 2026

A Model of Disturbed Flow-Induced Atherosclerosis in Mouse Carotid Artery by Partial Ligation and a Simple Method of RNA Isolation from Carotid Endothelium
11:00

A Model of Disturbed Flow-Induced Atherosclerosis in Mouse Carotid Artery by Partial Ligation and a Simple Method of RNA Isolation from Carotid Endothelium

Published on: June 22, 2010

30.3K
A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

13.8K

Area of Science:

  • Molecular Biology
  • Cardiovascular Research
  • Genetics

Background:

  • Long noncoding RNAs (lncRNAs) are RNA molecules longer than 200 nucleotides with diverse regulatory functions.
  • Atherosclerosis is a complex cardiovascular disease involving inflammation and lipid accumulation in artery walls.
  • Emerging evidence implicates lncRNAs in the cellular mechanisms underlying atherosclerosis.

Purpose of the Study:

  • To review and summarize the current understanding of lncRNAs in atherosclerosis.
  • To highlight specific lncRNAs that influence atherogenesis.
  • To provide a foundation for future research into lncRNA-targeted therapies for atherosclerosis.

Main Methods:

  • Literature review of studies investigating lncRNAs in atherosclerosis.
  • Analysis of lncRNA roles in key cell types involved in atherosclerosis (VSMCs, ECs, macrophages).
  • Synthesis of findings on lncRNA involvement in atherogenic processes.

Main Results:

  • Numerous lncRNAs have been identified that modulate atherosclerosis progression.
  • lncRNAs impact vascular smooth muscle cell proliferation and migration.
  • lncRNAs influence endothelial cell function and inflammatory responses in macrophages.

Conclusions:

  • lncRNAs are critical players in the pathogenesis of atherosclerosis.
  • Understanding lncRNA functions offers potential therapeutic targets for cardiovascular disease.
  • Further investigation into lncRNA mechanisms is warranted to develop novel treatment strategies.